NALOXEGOL

FDA Drug Profile

Drug Details

Generic Name
NALOXEGOL
Brand Names
N/A
Application Number
Sponsor
Piramal Healthcare UK Limited
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
N/A
Active Ingredients
NALOXEGOL OXALATE

Indications and Usage

1 INDICATIONS AND USAGE MOVANTIK ® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation. MOVANTIK is an opioid antagonist indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation. (1)